Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Marie McAvoy

NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer

10th March 2022

Sciad Newswire / NanoSyrinx, a biotech company using engineering biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics…
Lab work

HydRegen receives funding to implement their proprietary enzyme platform into sustainable chemical processes

1st March 2022

HydRegen, the revolutionary bioscience company, enables sustainable chemical manufacturing using their proprietary enzyme based redox platform.
Cows

Mirico monitors impact of cattle grazing and fertiliser strategies on agricultural greenhouse gas emissions

1st March 2022

Mirico is collaborating with partners in the agricultural sector to baseline and understand greenhouse gas emissions associated with cattle farms, helping with sector plans to reach net zero.
manufacture

Q5D Technology announces a $2.5m seed investment to take its technology and business to the next stage

2nd February 2022

Q5D Technology is excited to announce a $2.5m seed investment in order to take its technology and business to the next stage.
OSS banner

Oxford Space Systems in ground-breaking programme for Innovative Space Solutions

1st February 2022

Oxford Space Systems (OSS) has announced an investment round, subject to final completion, of approximately £4 million to accelerate development of its existing deployable antenna…
Medication

CellCentric secures investment from the American Cancer Society’s impact venture capital fund

26th January 2022

Inobrodib is the first drug to target p300/CBP, a new way to treat specific cancers.  Following a successful Phase I campaign, new funding will be used to…
Gherkin

Review of 2021

21st January 2022

A year of global challenges emphasises the role of science and technology in our changing world.
Viewing screen

Helix Geospace raises £3m Seed funding to take its world-leading GPS antennas into mass production

17th December 2021

Helix Geospace, the leading innovator in antenna and RF (radio frequency) technology, is pleased to announce that it has raised £3million seed funding in a round led by Bloc Ventures.
Keith Thompson

An Interview with Keith Thompson – Chair of NK:IO

16th December 2021

Keith Thompson is the current chair of biotech start-up NK:IO. He’s also chair of the Pharma Advisory Board of Deep Science Ventures and acted as industry advisor to the Vaccines Taskforce.
surveying

Mirico joins industry consortium to guide European methane emissions regulation

8th December 2021

With the Global Methane Pledge launched at COP26 and new regulation being developed to cover Europe, Mirico’s methane emissions monitoring solution was showcased as…
Atheras Analytics Satelite

Atheras Analytics receives funding from UKI2S to launch its SaaS platform to improve satellite link availability

11th November 2021

Atheras Analytics, a UK-based company in the satellite telecommunications sector, has secured funding from the UK Innovation & Science Seed Fund (UKI2S).

Gilad Gershon

CEO Spotlight: Gilad Gershon, CEO of Tropic Biosciences

8th November 2021

Founded by Gilad Gershon and Dr Eyal Maori, Tropic Biosciences uses cutting-edge technologies to develop tropical crop varieties with enhanced nutritional benefits…
Andrew Mackintosh

How investing public money can support the development of technologies for a greener future

25th October 2021

In the lead up to COP26, Andrew Mackintosh, the newly appointed Chair of UK Innovation and Science Seed Fund (UKI2S) Advisory Board…
Ann Kramer

CEO Spotlight: Ann Kramer, CEO The Electrospinning Company

15th October 2021

The Electrospinning Company (ESC) was established in 2010 as a spin-out by the UK Science and Technology Facilities Council (STFC). ESC is located in purpose-built…
Quantum Dice team

Quantum Dice raises £2 million in pre-seed funding to revolutionise the security of encryption keys

12th October 2021

Oxford University Spinout, Quantum Dice, announces the completion of its pre-seed fundraise, where a £1 million venture capital consortium was led by the notable venture capital fund…
Horizon 37

Supporting the leaders of tomorrow’s scale ups with Horizon 37

21st September 2021

UKI2S is proud to invest in innovative early-stage companies, helping them to commercialise their research.
Neil Martin

CEO Spotlight: Neil Martin, CEO Vector Photonics

6th September 2021

Vector Photonics is a spin-out from the University of Glasgow, based on world-leading semiconductor research led by Professor Richard Hogg.
national cancer institute

Presymptom Health Receives Additional Funding to Support its Trials of an Early Test for Sepsis

25th August 2021

Medical technology company Presymptom Health has successfully closed its seed round funding to support the development of its pioneering blood test for the early detection of sepsis.
John Sinden

Cell and Gene Therapy: challenges, developments and exciting possibilities

17th August 2021

Drug discovery and development has never been more of a focus, for the public, researchers and investors. Cell and gene therapies are often regarded as a silver bullet of the future, but what challenges stand in the way?
Andrew Mackintosh

Andrew Mackintosh appointed as new Chair of UK Innovation and Science Seed Fund Advisory Board

19th July 2021

The UK Innovation and Science Seed Fund (UKI2S) is pleased to announce the appointment of Dr Andrew Mackintosh as the new Chair of its Advisory Board.
Medication

NanoSyrinx raises £6.2m to develop its engineering biology platform for targeted intracellular engineering

19th July 2021

NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeutic modalities, has raised a further £6.2m of seed financing…
Jonathan Wogel

CEO Spotlight: Jonathan Wogel, Executive Chairman, Zentraxa

8th July 2021

Jonathan Wogel, Executive Chairman of UKI2S portfolio company Zentraxa, has a career of two halves, starting his journey in large, international corporations…
Alzheimer’s

Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s disease

23rd June 2021

Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes, and guide possible use of drug therapy…
Crescendo

Funding boost supports growing high-tech companies in the UK

21st June 2021

UKRI has provided a £10million funding boost to the UK Innovation and Science Seed Fund (UKI2S), supporting early-stage businesses arising from world-class…
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.